Ioannis Manolitsis
Overview
Explore the profile of Ioannis Manolitsis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapriniotis K, Manolitsis I, Juliebo-Jones P, Pietropaolo A, Tsaturyan A, Tonyali S, et al.
Expert Opin Pharmacother
. 2025 Jan;
26(3):301-311.
PMID: 39801071
Introduction: BPH/male LUTS is a prevalent condition in the aging male population with multifactorial pathophysiology. Pharmacotherapy remains the cornerstone of treatment in patients who fail conservative treatment. 5-α-Reductase inhibitors (5-ARIs)...
2.
Reporting and Grading of Complications in Urological Surgery: Current Trends and Future Perspectives
Katsimperis S, Bellos T, Manolitsis I, Kyriazis I, Angelopoulos P, Neophytou P, et al.
Urol Res Pract
. 2024 Nov;
50(3):154-159.
PMID: 39495560
There has been a growing need for enhancements in healthcare delivery, especially for the improvement of surgical outcomes. Therefore, implementing consistent reporting of complications enables the evaluation of data quality...
3.
Manolitsis I, Feretzakis G, Tzelves L, Anastasiou A, Koumpouros Y, Verykios V, et al.
Healthcare (Basel)
. 2024 Sep;
12(18).
PMID: 39337158
Background: The ASCAPE project aims to improve the health-related quality of life of cancer patients using artificial intelligence (AI)-driven solutions. The current study employs a comprehensive dataset to evaluate sleep...
4.
Tzelves L, Kapriniotis K, Feretzakis G, Katsimperis S, Manolitsis I, Juliebo-Jones P, et al.
Arch Esp Urol
. 2024 Sep;
77(7):708-717.
PMID: 39238293
Background: This study aims to provide a comprehensive overview of the current literature on the utilisation of ChatGPT in the fields of clinical medicine, urology, and academic medicine, while also...
5.
Katsimperis S, Pinitas A, Zerva M, Bellos T, Manolitsis I, Feretzakis G, et al.
Life (Basel)
. 2024 Jul;
14(7).
PMID: 39063621
Prostate cancer is the second most common cancer among men, with many treatment modalities available for patients, such as radical prostatectomy, external beam radiotherapy, brachytherapy, high-intensity focused ultrasound, cryotherapy, electroporation...
6.
Katsimperis S, Tzelves L, Tandogdu Z, Ta A, Geraghty R, Bellos T, et al.
Eur Urol Focus
. 2024 May;
10(5):859.
PMID: 38749880
No abstract available.
7.
Bellos T, Manolitsis I, Katsimperis S, Juliebo-Jones P, Feretzakis G, Mitsogiannis I, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730727
With the rapid increase in computer processing capacity over the past two decades, machine learning techniques have been applied in many sectors of daily life. Machine learning in therapeutic settings...
8.
Katsimperis S, Tzelves L, Bellos T, Manolitsis I, Mourmouris P, Kostakopoulos N, et al.
Cent European J Urol
. 2024 Apr;
77(1):15-21.
PMID: 38645804
Introduction: The aim of this review was to assess the outcomes of partial nephrectomy using indocyanine green (ICG) regarding ischemia time, positive surgical margins (PSM), estimated blood loss (EBL) and...
9.
Katsimperis S, Kapriniotis K, Manolitsis I, Bellos T, Angelopoulos P, Juliebo-Jones P, et al.
Expert Opin Investig Drugs
. 2024 Feb;
33(4):359-370.
PMID: 38421373
Introduction: Benign prostatic hyperplasia (BPH), as a clinical entity that affects many people, has always been in the forefront of interest among researchers, pharmaceutical companies, and physicians. Patients with BPH...
10.
Angelopoulos P, Kapsalos-Dedes S, Manolitsis I, Katsimperis S, Bellos T, Kyriazis I, et al.
Cureus
. 2024 Feb;
16(1):e52376.
PMID: 38361714
Urachal cancer is a rare and aggressive type of cancer, frequently characterized by a lack of prominent symptoms. We herein report a case of a 50-year-old female with mucin-producing adenocarcinoma...